Stryker Corporation (SYK)
NYSE: SYK · IEX Real-Time Price · USD
341.09
+0.57 (0.17%)
At close: May 31, 2024, 4:00 PM
343.12
+2.03 (0.60%)
After-hours: May 31, 2024, 7:12 PM EDT
Stryker Market Cap
Stryker has a market cap or net worth of $129.94 billion as of May 31, 2024. Its market cap has increased by 24.85% in one year.
Market Cap
129.94B
Enterprise Value
140.40B
1-Year Change
24.85%
Ranking
Category
Stock Price
$341.09
Market Cap Chart
Since December 1, 1998, Stryker's market cap has increased from $4.26B to $129.94B, an increase of 2,953.20%. That is a compound annual growth rate of 14.34%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 30, 2024 | 129.72B | -0.18% |
May 29, 2024 | 129.96B | 0.54% |
May 28, 2024 | 129.26B | 1.12% |
May 24, 2024 | 127.82B | 1.64% |
May 23, 2024 | 125.76B | -1.58% |
May 22, 2024 | 127.78B | 1.49% |
May 21, 2024 | 125.91B | 0.24% |
May 20, 2024 | 125.61B | -1.48% |
May 17, 2024 | 127.50B | 0.21% |
May 16, 2024 | 127.23B | 0.60% |
May 15, 2024 | 126.47B | 2.37% |
May 14, 2024 | 123.54B | -0.08% |
May 13, 2024 | 123.64B | -1.82% |
May 10, 2024 | 125.93B | -0.08% |
May 9, 2024 | 126.04B | 0.48% |
May 8, 2024 | 125.44B | -0.86% |
May 7, 2024 | 126.53B | 2.04% |
May 6, 2024 | 124.00B | -0.90% |
May 3, 2024 | 125.12B | 0.56% |
May 2, 2024 | 124.43B | -0.45% |
May 1, 2024 | 125.00B | -2.31% |
Apr 30, 2024 | 127.96B | -0.70% |
Apr 29, 2024 | 128.86B | 0.97% |
Apr 26, 2024 | 127.62B | -0.46% |
Apr 25, 2024 | 128.21B | 0.09% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Danaher | 187.20B |
Abbott Laboratories | 176.99B |
Amgen | 161.47B |
Pfizer | 159.80B |
Intuitive Surgical | 143.08B |
Sanofi | 119.85B |
Elevance Health | 117.91B |
Vertex Pharmaceuticals | 114.33B |